Societe De Therapeutique Marocaine operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Societe De Therapeutique Marocaine with three other
pharmaceutical manufacturers in Africa:
sales of 511.20 million Moroccan Dirhams [US$53.59 million]
Glaxo Smithkline Consumer Nigeria PLC
(16.09 billion Naira [US$52.61 million]
of which 64%
was Pharmaceuticals), and
Fidson Healthcare Limited
based in Nigeria
(14.06 billion Naira [US$45.97 million]
Societe De Therapeutique Marocaine reported sales of 1.42 billion Moroccan Dirhams (US$148.35 million)
December of 2017.
increase of 6.7%
versus 2016, when the company's sales were 1.33 billion Moroccan Dirhams.
Sales at Societe De Therapeutique Marocaine have increased during each of the previous five years
(and since 2012, sales have increased a total of 39%).